• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    10/13/23 1:14:35 PM ET
    $AG
    $AMC
    $BDC
    $BLPH
    Precious Metals
    Basic Materials
    Movies/Entertainment
    Consumer Discretionary
    Get the next $AG alert in real time by email

    Gainers

    • Sigma Additive Solutions, Inc. (NASDAQ:SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares climbed 102% to $0.7961 after gaining more than 6% on Thursday.
    • Shift Technologies, Inc. (NASDAQ:SFT) gained 60% to $0.2145, after falling around 21% on Thursday.
    • C3is Inc. (NASDAQ:CISS) gained 32% to $0.5625.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results.
    • Versus Systems Inc. (NASDAQ:VS) shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday.
    • Outlook Therapeutics, Inc. (NASDAQ:OTLK) gained 26% to $0.3448
    • SunOpta Inc. (NASDAQ:STKL) gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature's Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results.
    • PSQ Holdings, Inc. (NYSE:PSQH) climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth.
    • EHang Holdings Limited (NASDAQ:EH) jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China.
    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia.
    • Celularity Inc. (NASDAQ:CELU) rose 17.7% to $0.3179.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) gained 16% to $0.3826.
    • Hecla Mining Company (NYSE:HL) climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4.
    • Viasat, Inc. (NASDAQ:VSAT) climbed 13.5% to $19.06.
    • Coeur Mining, Inc. (NYSE:CDE) gained 13.2% to $2.5399.
    • Groupon, Inc. (NASDAQ:GRPN) jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target.
    • Synchronoss Technologies, Inc. (NASDAQ:SNCR) surged 13% to $0.5426.
    • Oblong, Inc. (NASDAQ:OBLG) shares gained 12.1% to $0.3286.
    • Blue Star Foods Corp. (NASDAQ:BSFC) shares gained 10% to $0.2201.
    • Staffing 360 Solutions, Inc. (NASDAQ:STAF) rose 9.2% to $0.7550.
    • Dollar General Corporation (NYSE:DG) climbed 8.5% to $110.50 after the company updated financial guidance for FY23 and announced Todd Vasos has been appointed CEO.
    • First Majestic Silver Corp. (NYSE:AG) climbed 8.5% to $5.34.
    • The Progressive Corporation (NYSE:PGR) gained 7.7% to $154.27 after the company reported third-quarter results.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 6.9% to $0.3976. RedHill Biopharma recently said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S. Army-funded in vivo Ebola virus study, making it the first host-directed molecule to show activity in the Ebola virus disease.
    • JPMorgan Chase & Co. (NYSE:JPM) gained 3.6% to $151.09 as the company reported better-than-expected earnings for its third quarter on Friday.
    • Wells Fargo & Company (NYSE:WFC) gained 3.2% to $41.03 following third-quarter earnings.

    Losers

    • Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) fell 53.4% to $0.1852.
    • Outset Medical, Inc. (NASDAQ:OM) shares fell 47.6% to $3.55. The company announced preliminary revenue for the third quarter of $30.4 million, below the consensus estimate of $36.03 million.
    • MSP Recovery, Inc. (NASDAQ:LIFW) dipped 44% to $1.8109.
    • SMART Global Holdings, Inc. (NASDAQ:SGH) fell 40.4% to $14.04 after the company reported worse-than-expected fourth-quarter financial results and issued a weak forecast for the first quarter.
    • Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) declined 38.3% to $18.66 after the company reported topline data from its Phase 3 INTUNE study of pitolisant for IH, noting no statistically significant difference was observed
    • between pitolisant and placebo on ESS.
    • Secoo Holding Limited (NASDAQ:SECO) fell 38% to $0.6327.
    • FLJ Group Limited (NASDAQ:FLJ) fell 31.9% to $0.2301.
    • PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) declined 27.7% to $1.7999. PMV Pharmaceuticals recently announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a favorable safety profile.
    • LQR House Inc. (NASDAQ:LQR) declined 26.6% to $0.1739 after the company announced the pricing of a $5.4 million public offering of 28,421,053 shares of common stock at a price of $0.19 per share.
    • Belden Inc. (NYSE:BDC) fell 25.7% to $70.76 after the company lowered third-quarter revenue guidance below estimates.
    • Scully Royalty Ltd. (NYSE:SRL) declined 25% to $4.1990.
    • Charles & Colvard, Ltd. (NASDAQ:CTHR) fell 23% to $0.44 following quarterly results.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) fell 21.3% to $13.80 after a recent report by the City University of New York implicated a long-time collaborator of the company in scientific misconduct related to 20 research papers.
    • Edesa Biotech, Inc. (NASDAQ:EDSA) shares fell 21.1% to $3.8501 after jumping around 80% on Thursday. Edesa Biotech secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
    • Prestige Wealth Inc. (NASDAQ:PWM) fell 18.7% to $3.43.
    • ReShape Lifesciences Inc. (NASDAQ:RSLS) fell 17.9% to $0.2795, after surging over 25% on Thursday.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 17.8% to $0.8301. Nuwellis reported pricing of $2.25 million public offering of Series J convertible redeemable preferred stock and warrants.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 15.7% to $0.8850, after jumping 28% on Thursday.
    • BeyondSpring Inc. (NASDAQ:BYSI) shares fell 15.1% to $0.9089, after jumping 46% on Thursday.
    • ATRenew Inc. (NYSE:RERE) declined 13.4% to $1.8350.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) fell 11.5% to $6.90.
    • Sterling Infrastructure, Inc. (NASDAQ:STRL) fell 11.2% to $68.79.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 9.9% to $9.91.
    • LogicMark, Inc. (NASDAQ:LGMK) shares fell 9.7% to $1.76 after jumping around 25% on Thursday.
    • Society Pass Incorporated (NASDAQ:SOPA) shares fell 9.7% to $0.3201. Society Pass shares jumped around 33% on Thursday after the company announced an equity line of up to $40 million to invest into operating subsidiaries projected to go public in 2024.
    • Ribbon Communications Inc. (NASDAQ:RBBN) declined 8.8% to $2.2050.
    • Hormel Foods Corporation (NYSE:HRL) fell 4.5% to $30.93 following the company's Thursday investor day event. Additionally, Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $33 to $29.
    • JD.com, Inc. (NASDAQ:JD) fell 4.1% to $26.71. Macquarie downgraded JD.com from Outperform to Neutral and lowered the price target from $52 to $32, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight and slashed the price target from $55 to $33.

    Now Read This: Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things'

    Get the next $AG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AG
    $AMC
    $BDC
    $BLPH

    CompanyDatePrice TargetRatingAnalyst
    Sterling Infrastructure Inc.
    $STRL
    4/23/2026$572.00Overweight
    KeyBanc Capital Markets
    JD.com Inc.
    $JD
    4/17/2026Neutral → Buy
    Arete
    Sterling Infrastructure Inc.
    $STRL
    4/16/2026$510.00Buy
    Argus
    JD.com Inc.
    $JD
    4/14/2026Neutral → Outperform
    Macquarie
    Hormel Foods Corporation
    $HRL
    4/9/2026$23.00Overweight → Neutral
    Analyst
    ViaSat Inc.
    $VSAT
    4/8/2026$49.00Underweight → Equal Weight
    Barclays
    Tango Therapeutics Inc.
    $TNGX
    4/3/2026$30.00Buy
    Canaccord Genuity
    Tango Therapeutics Inc.
    $TNGX
    4/2/2026$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $AG
    $AMC
    $BDC
    $BLPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on Sterling Infrastructure with a new price target

    KeyBanc Capital Markets initiated coverage of Sterling Infrastructure with a rating of Overweight and set a new price target of $572.00

    4/23/26 7:56:54 AM ET
    $STRL
    Military/Government/Technical
    Industrials

    JD.com upgraded by Arete

    Arete upgraded JD.com from Neutral to Buy

    4/17/26 9:26:04 AM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    Argus initiated coverage on Sterling Infrastructure with a new price target

    Argus initiated coverage of Sterling Infrastructure with a rating of Buy and set a new price target of $510.00

    4/16/26 7:54:24 AM ET
    $STRL
    Military/Government/Technical
    Industrials

    $AG
    $AMC
    $BDC
    $BLPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Nijhawan Pardeep bought $6,599 worth of shares (1,000 units at $6.60), increasing direct ownership by 0.16% to 628,813 units (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/10/26 5:02:16 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nijhawan Pardeep bought $39,000 worth of shares (10,000 units at $3.90) (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/6/26 5:01:15 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nijhawan Pardeep bought $42,560 worth of shares (10,000 units at $4.26) (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/5/26 5:01:11 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $AMC
    $BDC
    $BLPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hormel Foods Completes Sale of Whole-Bird Turkey Business to Life-Science Innovations

    Hormel Foods continues to own JENNIE-O® brand and value-added turkey product portfolioAUSTIN, Minn., April 24, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced it has completed the previously announced sale of its whole-bird turkey business to Willmar, Minn.-based Life-Science Innovations (LSI). LSI has taken ownership of an existing whole-bird production facility in Melrose, Minn., a feed mill in Swanville, Minn., and associated transportation assets. The production facility will now operate under the name Lega

    4/24/26 3:00:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    PSQ Holdings Announces First Quarter 2026 Financial Results Release Date & Conference Call

    PSQ Holdings, Inc. (NYSE:PSQH) (the "Company"), today announced it will host a teleconference and webcast to discuss its first quarter 2026 results beginning at 9:00 a.m. EDT on Thursday, May 7, 2026. The Company will issue a news release containing first quarter 2026 results on May 7, 2026, before the U.S. stock market opens. The conference call can be accessed live through a link on the PSQ Holdings Investor Relations website at investors.publicsquare.com. During the webcast, the company will take both inbound questions received ahead of the call and questions from equity research analysts. Questions may be submitted starting April 30, 2026, through the Say Technologies platform at app.

    4/23/26 4:15:00 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

    ISELIN, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) ("Outlook Therapeutics" or the "Company"), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 16,129,033 shares of its common stock at an offering price of $0.31 per share of common stock. Additionally, in a concurrent private placement, the Company issued unregistered warrants to purchase up to an aggregate of 16,129,033 shares of common stock at an exercise price

    4/23/26 4:05:00 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AG
    $AMC
    $BDC
    $BLPH
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Outlook Therapeutics Inc.

    SCHEDULE 13G - Outlook Therapeutics, Inc. (0001649989) (Subject)

    4/24/26 5:17:31 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nuwellis Inc. filed SEC Form 8-K: Other Events

    8-K - Nuwellis, Inc. (0001506492) (Filer)

    4/24/26 5:00:23 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    JP Morgan Chase & Co. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - JPMORGAN CHASE & CO (0000019617) (Filer)

    4/24/26 4:16:13 PM ET
    $JPM
    Major Banks
    Finance

    $AG
    $AMC
    $BDC
    $BLPH
    Leadership Updates

    Live Leadership Updates

    View All

    PMV Pharmaceuticals Announces Board Chair Transition

    PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (("PMV Pharma" or the "Company", NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced a leadership transition on its Board of Directors. Laurie Stelzer, who has served as a member of the Board since 2020, has been appointed Chair of the Board, succeeding Rich Heyman, Ph.D., effective at the Company's 2026 Annual Meeting of Stockholders on June 4, 2026 (the "Meeting"). Dr. Heyman's term as a member and Chair of the Board will expire at the Meeting, and Dr. Heyman will not stand for reelection. Ms. Stelzer brings more than 25

    4/22/26 8:00:00 AM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ribbon Appoints Louis Silver to its Board of Directors

    PLANO, Texas, April 15, 2026 /PRNewswire/ -- Ribbon Communications Inc. (NASDAQ:RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced the appointment of Louis Silver to its Board of Directors. "We are pleased to have Lou join the Board" said Shaul Shani, Chairman of the Board at Ribbon.  "Lou has a long history of working with technology companies and brings significant international experience in finance, corporate governance, and regulatory compliance matters.  We believe he will be a great addition for us," continue

    4/15/26 8:30:00 AM ET
    $RBBN
    EDP Services
    Technology

    Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer

    COMPANY REITERATES ITS 2026 NET REVENUE GUIDANCE OF OVER $1 BILLION IN WAKIX SALES Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), today announced the appointment of Glenn Reicin as Chief Financial Officer, effective immediately, supporting Harmony's continued focus on strategic growth, financial strength, and long‑term value creation. Harmony is also reiterating its 2026 net product revenue guidance of $1.0 to $1.04 billion. Mr. Reicin is a seasoned biopharmaceutical executive with extensive experience across publicly traded and privately held companies, guiding them through key growth inflection points. With his experience as a sell-side analyst, investor and biotech CFO, he brings

    4/14/26 8:05:00 AM ET
    $HRMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $AMC
    $BDC
    $BLPH
    Financials

    Live finance-specific insights

    View All

    Hormel Foods Completes Sale of Whole-Bird Turkey Business to Life-Science Innovations

    Hormel Foods continues to own JENNIE-O® brand and value-added turkey product portfolioAUSTIN, Minn., April 24, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced it has completed the previously announced sale of its whole-bird turkey business to Willmar, Minn.-based Life-Science Innovations (LSI). LSI has taken ownership of an existing whole-bird production facility in Melrose, Minn., a feed mill in Swanville, Minn., and associated transportation assets. The production facility will now operate under the name Lega

    4/24/26 3:00:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    PSQ Holdings Announces First Quarter 2026 Financial Results Release Date & Conference Call

    PSQ Holdings, Inc. (NYSE:PSQH) (the "Company"), today announced it will host a teleconference and webcast to discuss its first quarter 2026 results beginning at 9:00 a.m. EDT on Thursday, May 7, 2026. The Company will issue a news release containing first quarter 2026 results on May 7, 2026, before the U.S. stock market opens. The conference call can be accessed live through a link on the PSQ Holdings Investor Relations website at investors.publicsquare.com. During the webcast, the company will take both inbound questions received ahead of the call and questions from equity research analysts. Questions may be submitted starting April 30, 2026, through the Say Technologies platform at app.

    4/23/26 4:15:00 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

    Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on May 7, 2026, at 8:30 a.m. ET to discuss the results. To participate in the call, please dial 800-274-8461 (domestic) or 203-518-9814 (international or alternate), and reference passcode HRMYQ126. It is recommended that you dial in at least 10 minutes prior to the call. The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/. About Harmony Biosciences Harmony Bioscien

    4/23/26 8:05:00 AM ET
    $HRMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $AMC
    $BDC
    $BLPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Prestige Wealth Inc.

    SC 13G/A - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:04 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    $AG
    $AMC
    $BDC
    $BLPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Barach Philip Alan

    3 - Celularity Inc (0001752828) (Issuer)

    4/24/26 6:41:27 PM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Barach Daniele Wolf

    3 - Celularity Inc (0001752828) (Issuer)

    4/24/26 6:41:04 PM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Philip & Daniele Barach Family Trust

    3 - Celularity Inc (0001752828) (Issuer)

    4/24/26 6:40:13 PM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care